MedPath

Effect of Sharpunkhadi Granules in Childhood Sickle Cell Disease

Phase 3
Conditions
Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs
Registration Number
CTRI/2023/05/052463
Lead Sponsor
Parul Institute of Ayurved
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Pre diagnosed cases will be taken only with positive sickling report

2 Age between 3 years to 16 years irrespective of gender caste religion

3 Patients with sign and symptoms of sickle cell disease

4 Hb >6.5 gm% and <11.5 gm%

5 Hb electrophoresis reporting % of Hb S >10 gm%

6 Serum Bilirubin less than 3.0 mg/dL

Exclusion Criteria

1 Age less than 3 years and greater than 16 years

2 Patients with known case of hepatic and renal dysfunction and chronic cardiac dysfunction

3 SCA associated with other known diseases like Diabetes Mellitus Hypertension Thalassemia

4 Hb < 6.5 gm % and >11.5 gm %

5 Serum bilirubin level more than 3.0mg/dL

6 Known case of other haemoglobinopathies and haematological diseases other than sickle cell anaemia G6PD thalassemia sickle cell beta thalassemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Blood indices including Hb% MCV MCHTimepoint: 30 and 60 days
Secondary Outcome Measures
NameTimeMethod
Improvement in WHO QoL of sickle childrenTimepoint: 30 and 60 days
© Copyright 2025. All Rights Reserved by MedPath